Nurse Practitioner · Johnstown, PA
NPI
1295219384
Since 2018
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1 Tech Park Dr Ste 1130
Johnstown, PA, 15901
Phone (814) 475-8760
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
396 services
Medicare patients, 2024
110
Average age 72
Drug cost, 2024
$2.3M
5,454 prescriptions
Company payments, 2025
$610
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katie L Ruiz was code 99214 (office e&m - established), 244 times for 109 patients. In total Katie L Ruiz billed 396 services in 5 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 244 | 109 | $78.28 | $19K |
| 95251 Test - Miscellaneous | Office | 102 | 51 | $21.92 | $2,236 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 38 | $10.60 | $413 |
By year: 2022 $14K for 193 services; 2023 $3,296 for 48 services; 2024 $23K for 396 services.
Medicare prescription drug claims, 2024
In 2024, the drug Katie L Ruiz prescribed most often to Medicare patients was Levothyroxine Sodium, with 500 prescriptions and refills. In total Katie L Ruiz wrote 5,454 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 500 | 1,014 | 128 | $5,622 |
| Ozempic Semaglutide | 350 | 480 | 72 | $444K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 320 | 817 | 116 | $48K |
| Metformin Hcl Generic | 313 | 758 | 87 | $3,508 |
| Glipizide Generic | 311 | 703 | 95 | $3,469 |
| Jardiance Empagliflozin | 273 | 492 | 72 | $278K |
| Metformin Hcl Er Metformin Hcl | 249 | 613 | 82 | $4,564 |
| Glipizide Er Glipizide | 196 | 451 | 53 | $3,528 |
| Humalog Kwikpen U-100 Insulin Lispro | 192 | 419 | 78 | $73K |
| Tradjenta Linagliptin | 183 | 325 | 45 | $155K |
| Synthroid Levothyroxine Sodium | 153 | 342 | 42 | $7,252 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 144 | 394 | 65 | $22K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 133 | 279 | 38 | $128K |
| Mounjaro Tirzepatide | 121 | 132 | 16 | $134K |
| Trulicity Dulaglutide | 112 | 150 | 22 | $142K |
Brand drugs: 2,829 claims; generic drugs: 2,139 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katie L Ruiz $610 ($610 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novo Nordisk Inc with $190.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $190 |
| Medtronic, Inc. MDT | 3 | $88.12 |
| Abbvie Inc. ABBV | 4 | $85.83 |
| Insulet Corporation PODD | 2 | $41.85 |
| Lilly USA, LLC LLY | 2 | $36.18 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $35.82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34.74 |
| Amgen Inc. AMGN | 2 | $32.91 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $25.32 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $19.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.